Skip to main content

Table 3 Demographics and clinical features of patients belonging to Metabotype IV and patients classified as very high aggressiveness that do not belong to Metabotype IV

From: Inflammatory metabolic profile of South African patients with prostate cancer

Patient ID Ethnicity Collection date Date of last visit Date of death Follow-up (day)c Age (year) PSA (ng/mL) Gleason score DRE NCCN classification GlycB rankd Metabotype Note
SAPC0159 Black 2017/03/01 2017/03/23   22 75.2 >5000 5+5 T3/T4 Metastatic 3 IV  
SAPC0090 Colored 2015/05/08   2015/06/27 50 78.2 6.3 3+3 T1c Low 8 IV a
SAPC0192 Colored 2017/07/31   2017/12/19 141 80.9 41.68 4+5 T2a Very high 7 III b
SAPC0080 Black 2014/10/31 2015/04/21   172 77.8 738 3+5 T4 Very high 2 IV  
SAPC0180 Black 2017/06/23 2017/12/12   172 58.1 >5000 5+5 T3/T4 Very high 1 IV  
SAPC0249 Colored 2018/03/25 2019/01/07   288 63 1070 5+4 T3 Very high 4 IV  
SAPC0078 White 2014/11/07   2015/10/31 358 74.3 135.79 5+5 T4 Very high 5 IV  
SAPC0193 Colored 2017/08/11 2019/04/26   623 63.5 48.85 3+4 T3 Very high 9 III  
SAPC0070 Colored 2014/01/08   2015/12/11 702 65.4 34.8 4+5 T2b Very high 13 II  
SAPC0191 White 2017/07/28   2019/08/03 736 61.8 576 5+4 T3 Very high 6 IV  
SAPC0195 Black 2017/08/13 2020/01/30   900 87.2 26.53 4+5 T3 Very high 11 III  
SAPC0120 Black 2016/10/03 2019/09/30   1092 82.3 289.9 4+5 T3 Very high 14 II  
SAPC0108 Colored 2016/06/27   2020/04/17 1390 56.6 96.3 3+4 T4 Very high 12 III  
SAPC0076 Colored 2014/09/26 2020/06/04   2078 63.5 140.42 3+4 T3/T4 Very high 10 III  
  1. aThe patient was diagnosed with pancreas cancer 19 days after sample collection
  2. bThe patient died for bone metastasis 5 months after sample collection
  3. cNumber of days between the date of collection and the date of last visit at hospital or the date of death (if recorded)
  4. dThis number represent the rank of order of the GlycB values starting from the highest value